NCT06111599

Thermovision-controlled Lumbar Sympathetic Blockade in Chronic Limb-threatening Ischemia Treatment

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: EPC Education s.r.o. · Academic / Other
• Sex: All
• Age: 20 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Thermovision-controlled lumbar sympathetic blockade in chronic limb-threatening ischemia treatment

Detailed description

Chronic limb-threatening ischemia (CLTI), the end-stage of lower extremity artery disease (LEAD), occurs with growing prevalence around the globe and is associated with increased healthcare costs. CLTI is defined by the presence of LEAD in combination with rest pain, gangrene, or lower limb ulceration lasting more than two weeks. Despite unclear results of abdominal surgical lumbar sympathectomy, novel interventional minimally invasive fluoroscopy-guided procedures seem to be promising. A prospective interventional study will be conducted, primarily targeting patients afflicted by critical limb ischemia, with the incorporation of thermal vision control and tissue oxygen monitoring.

Conditions

• Chronic Limb-Threatening Ischemia

Interventions

Type	Name	Description
PROCEDURE	lumbar sympathetic blockade	Skiascopic-guided lumbar sympathetic blockade with the administration of local anesthetic

Timeline

• Start date: 2023-10-22
• Primary completion: 2024-08-01
• Completion: 2026-08-31
• First posted: 2023-11-01
• Last updated: 2023-11-01

Locations

1 site across 1 country: Slovakia